Why the study?
Do pressor amines affect cardiac output in patients with acute hypotension and shock?
Do pressor amines affect cardiac output in patients with acute hypotension and shock?
Answers are grounded in this paper and cite their sources.
This study aims to provide objective hemodynamic measurements to determine if pressor amines reduce cardiac output in patients with acute hypotension and shock.
T HE rationale for the therapeutic use of sympathomimetic amines in patients with shock is disputed.Nickerson, citing ex- perimental studies in animals and clinical ob- servations, has favored the view that in- creased adrenergic vasoconstriction resulting from such therapy potentiates shock.1 2 Lille- hei, Longerbeam, and their co-workers3' 4 re- ported that norepinephrine administered to dogs made hypotensive with endotoxin leads to reduction in visceral blood flow.Except in terminal stages, most types of shock are not attended by a decrease in arterial re- sistance.5-8Circulating levels of endogenous adrenal medullary secretions have been shown to increase, especially during initial stages of shock; their significance in relation to vascular reactivity, however, remains to be clarified.9Adrenal medullary insufficiency may occur in severe shock.'0The above-mentioned observations have supported the common assumption that ele- vation of blood pressure achieved after the use of pressor amines in p-atients with shock must result at the expense of a reduction in cardiac output.Objective studies on the he- modynamic effects of sympathomimetic drugs in patients with acute hypotension, however, are scanty."In the present investigation such measurements were made during treatment of 19 patients with acute hypotension and the clinical features of shock.
No takes yet. Share an insight, caveat, or question.
Sambhi et al. (1964) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: